[ID proteins in tumour initiation and progression]

Magdalena Pruszko1,2, Alicja Żylicz1

  • 1International Institute of Molecular and Cell Biology in Warsaw, 4 Ksiecia Trojdena St., 02-109 Warsaw, Poland.

Postepy Biochemii
|January 30, 2017
PubMed

Insights

ID proteins, regulators of cell differentiation, are implicated in cancer development. Their dysregulation in tumors contributes to cancer stem cell characteristics, metastasis, and angiogenesis, highlighting their potential as therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The ID protein family acts as DNA binding inhibitors, primarily affecting basic helix-loop-helix (bHLH) transcription factors.
  • Normally, ID genes inhibit differentiation in progenitor and stem cells, but their role can be context-dependent.
  • Dysregulation of ID gene expression (overexpression or silencing) is observed in various cancers.

Purpose of the Study:

  • To investigate the dual role of ID proteins as oncogenes and tumor suppressors in carcinogenesis.
  • To explore the contribution of ID proteins to cancer cell dedifferentiation and stem cell-like properties.
  • To understand the involvement of ID proteins in critical cancer processes like metastasis and angiogenesis.

Main Methods:

  • This study is a review and analysis of existing research on ID proteins in cancer.
  • Mechanisms of ID protein action in oncogenesis are examined through literature synthesis.
  • The implications of ID protein dysregulation in cancer are discussed.

Main Results:

  • ID proteins exhibit context-dependent roles, acting as oncogenes or tumor suppressors in different cancers.
  • Abnormal ID protein levels promote cancer cell dedifferentiation, self-renewal, and resistance to apoptosis and senescence.
  • ID proteins are significantly involved in promoting tumor metastasis and angiogenesis.

Conclusions:

  • The complex involvement of ID proteins in cancer highlights their significance in oncogenesis.
  • Targeting ID proteins presents a promising avenue for the development of novel anti-cancer therapies.
  • Further research into ID protein mechanisms is crucial for effective drug design.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.7K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K